ClinicalThought

Share

Program Content

Activities

  • Class II and III BRAF Alterations in Cancer
    Expanding Therapeutic Horizons: Targeting Non-V600 BRAF Mutations in Solid Tumors
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 02, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Kinnate Biopharma.

Kinnate Biopharma